Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1997 Nov;89(11):753–757.

Type 2 cytokine serum levels in healthy sickle cell disease patients.

S C Taylor 1, S J Shacks 1, Z Qu 1, P Wiley 1
PMCID: PMC2608277  PMID: 9375480

Abstract

Sickle cell disease (SCD) is characterized by significant morbidity and early mortality. Children with this hemoglobinopathy exhibit many of the manifestations associated with immunodeficiency disorders. Serum was obtained from 56 healthy SCD subjects and 45 normal healthy controls. Type 2 cytokines interleukin (IL)-4, IL-6, and IL-10 serum levels were measured. Concentrations were determined by reference to a standard curve, and results were expressed in pg/mL. Results revealed significant levels of IL-4 in 6 (13%) of 45 SCD patients compared with 1 (2%) of 45 controls. Increased levels of IL-6 were present in 35 (78%) of 45 SCD patients and 12 (41%) of 29 controls. Elevated levels of IL-10 were detectable in 13 (41%) of 42 SCD patients and 1 (4%) of 25 controls. High circulating levels of type 2 cytokines may suppress both humoral and cell-mediated immune functions in SCD, with resultant increased morbidity.

Full text

PDF
753

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdallah J. M., Kukuruga M., Nakeff A., Prasad A. S. Cell cycle distribution defect in PHA-stimulated T lymphocytes of sickle cell disease patients. Am J Hematol. 1988 Aug;28(4):279–281. doi: 10.1002/ajh.2830280414. [DOI] [PubMed] [Google Scholar]
  2. Bakshi S. S., Grover R., Cabezon E., Wethers D. L. Febrile episodes in children with sickle cell disease treated on an ambulatory basis. J Assoc Acad Minor Phys. 1991;2(2):80–83. [PubMed] [Google Scholar]
  3. Ballester O. F., Abdallah J. M., Prasad A. S. Lymphocyte subpopulation abnormalities in sickle cell anemia: a distinctive pattern from that of AIDS. Am J Hematol. 1986 Jan;21(1):23–27. doi: 10.1002/ajh.2830210104. [DOI] [PubMed] [Google Scholar]
  4. Balter M. AIDS research. Cytokines move from the margins into the spotlight. Science. 1995 Apr 14;268(5208):205–206. doi: 10.1126/science.7716511. [DOI] [PubMed] [Google Scholar]
  5. Boghossian S. H., Wright G., Webster A. D., Segal A. W. Investigations of host defence in patients with sickle cell disease. Br J Haematol. 1985 Mar;59(3):523–531. doi: 10.1111/j.1365-2141.1985.tb07339.x. [DOI] [PubMed] [Google Scholar]
  6. Brown A. K., Miller S. T., Agatisa P. Care of infants with sickle cell disease. Pediatrics. 1989 May;83(5 Pt 2):897–900. [PubMed] [Google Scholar]
  7. Cetiner S., Akoğlu T. F., Kilinç Y., Akoğlu E., Kümi M. Immunological studies in sickle cell disease: comparison of homozygote mild and severe variants. Clin Immunol Immunopathol. 1989 Oct;53(1):32–39. doi: 10.1016/0090-1229(89)90098-6. [DOI] [PubMed] [Google Scholar]
  8. Cole T. B., Smith S. J., Buchanan G. R. Hematologic alterations during acute infection in children with sickle cell disease. Pediatr Infect Dis J. 1987 May;6(5):454–457. doi: 10.1097/00006454-198705000-00008. [DOI] [PubMed] [Google Scholar]
  9. Corry J. M., Polhill R. B., Jr, Edmonds S. R., Johnston R. B., Jr Activity of the alternative complement pathway after splenectomy: comparison to activity in sickle cell disease and hypogammaglobulinemia. J Pediatr. 1979 Dec;95(6):964–969. doi: 10.1016/s0022-3476(79)80284-x. [DOI] [PubMed] [Google Scholar]
  10. Daeschner C. W., 3rd, Carpentieri U., Goldman A. S., Haggard M. E. Zinc deficiency and blood lymphocyte function with sickle cell disease. Scand J Haematol. 1985 Aug;35(2):186–190. doi: 10.1111/j.1600-0609.1985.tb01569.x. [DOI] [PubMed] [Google Scholar]
  11. INGRAM V. M. A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. Nature. 1956 Oct 13;178(4537):792–794. doi: 10.1038/178792a0. [DOI] [PubMed] [Google Scholar]
  12. Leikin S. L., Gallagher D., Kinney T. R., Sloane D., Klug P., Rida W. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics. 1989 Sep;84(3):500–508. [PubMed] [Google Scholar]
  13. Malavé I., Escalona E., Perdomo Y., Pocino M., Malavé D., Arends T. In vitro antibody synthesis by peripheral blood mononuclear cells from patients with sickle cell disease. Acta Haematol. 1990;84(2):89–94. doi: 10.1159/000205035. [DOI] [PubMed] [Google Scholar]
  14. Masood R., Lunardi-Iskandar Y., Moudgil T., Zhang Y., Law R. E., Huang C. L., Puri R. K., Levine A. M., Gill P. S. IL-10 inhibits HIV-1 replication and is induced by tat. Biochem Biophys Res Commun. 1994 Jul 15;202(1):374–383. doi: 10.1006/bbrc.1994.1938. [DOI] [PubMed] [Google Scholar]
  15. Moore C. M., Ehlayel M., Leiva L. E., Sorensen R. U. New concepts in the immunology of sickle cell disease. Ann Allergy Asthma Immunol. 1996 May;76(5):385–403. doi: 10.1016/S1081-1206(10)63453-9. [DOI] [PubMed] [Google Scholar]
  16. Natta C. L., Outschoorn I. M. IgG2 deficiency in sickle cell anaemia. Scand J Haematol. 1984 Aug;33(2):129–134. doi: 10.1111/j.1600-0609.1984.tb02387.x. [DOI] [PubMed] [Google Scholar]
  17. Neel J. V. The Inheritance of Sickle Cell Anemia. Science. 1949 Jul 15;110(2846):64–66. doi: 10.1126/science.110.2846.64. [DOI] [PubMed] [Google Scholar]
  18. PAULING L., ITANO H. A. Sickle cell anemia a molecular disease. Science. 1949 Nov 25;110(2865):543–548. doi: 10.1126/science.110.2865.543. [DOI] [PubMed] [Google Scholar]
  19. Pearson H. A., Gallagher D., Chilcote R., Sullivan E., Wilimas J., Espeland M., Ritchey A. K. Developmental pattern of splenic dysfunction in sickle cell disorders. Pediatrics. 1985 Sep;76(3):392–397. [PubMed] [Google Scholar]
  20. Pearson H. A. The kidney, hepatobiliary system, and spleen in sickle cell anemia. Ann N Y Acad Sci. 1989;565:120–125. doi: 10.1111/j.1749-6632.1989.tb24158.x. [DOI] [PubMed] [Google Scholar]
  21. Platt O. S., Brambilla D. J., Rosse W. F., Milner P. F., Castro O., Steinberg M. H., Klug P. P. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994 Jun 9;330(23):1639–1644. doi: 10.1056/NEJM199406093302303. [DOI] [PubMed] [Google Scholar]
  22. RANNEY H. M. Observations on the inheritance of sickle-cell hemoglobin and hemoglobin C. J Clin Invest. 1954 Dec;33(12):1634–1641. doi: 10.1172/JCI103044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ranney H. M. The spectrum of sickle cell disease. Hosp Pract (Off Ed) 1992 Jan 15;27(1):133-7, 141-4, 149-50 passim. doi: 10.1080/21548331.1992.11705347. [DOI] [PubMed] [Google Scholar]
  24. Rautonen N., Martin N. L., Rautonen J., Rooks Y., Mentzer W. C., Wara D. W. Low number of antibody producing cells in patients with sickle cell anemia. Immunol Lett. 1992 Dec;34(3):207–211. doi: 10.1016/0165-2478(92)90215-a. [DOI] [PubMed] [Google Scholar]
  25. Reiser H., Stadecker M. J. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med. 1996 Oct 31;335(18):1369–1377. doi: 10.1056/NEJM199610313351807. [DOI] [PubMed] [Google Scholar]
  26. Sanhadji K., Chout R., Gessain A., Sasco A. J., Yoyo M., Mezard F., de The G., Touraine J. L. Cell-mediated immunity in patients with sickle cell anaemia. Thymus. 1988;12(4):203–213. [PubMed] [Google Scholar]
  27. Smith J. A. The natural history of sickle cell disease. Ann N Y Acad Sci. 1989;565:104–108. doi: 10.1111/j.1749-6632.1989.tb24156.x. [DOI] [PubMed] [Google Scholar]
  28. Solanki D. L., Berdoff R. L. Severe mycoplasma pneumonia with pleural effusions in a patient with sickle cell-hemoglobin C(SC) disease. Case report and review of the literature. Am J Med. 1979 Apr;66(4):707–710. doi: 10.1016/0002-9343(79)91189-6. [DOI] [PubMed] [Google Scholar]
  29. Taylor S. C., Shacks S. J., Mitchell R. A. In vitro lymphocyte blastogenic responses and cytokine production in sickle cell disease patients with acute pneumonia. Pediatr Infect Dis J. 1996 Apr;15(4):340–344. doi: 10.1097/00006454-199604000-00011. [DOI] [PubMed] [Google Scholar]
  30. Taylor S. C., Shacks S. J., Villicana S. M., Olivares J., Dinkins G. A. Interferon production in sickle cell disease. Lymphokine Res. 1990 Fall;9(3):415–423. [PubMed] [Google Scholar]
  31. Taylor S., Shacks S., Villicana S., Olivares J., Dinkins G. Lymphocyte blastogenic responses in sickle cell disease. Immunol Invest. 1991 Dec;20(7):645–655. doi: 10.3109/08820139109026244. [DOI] [PubMed] [Google Scholar]
  32. Wang W., Herrod H., Presbury G., Wilimas J. Lymphocyte phenotype and function in chronically transfused children with sickle cell disease. Am J Hematol. 1985 Sep;20(1):31–40. doi: 10.1002/ajh.2830200106. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES